Report Detail
COVID-19 Impact on Global Subcutaneous Immunotherapy Market Size, Status and Forecast 2020-2026
- RnM3986185 |
- 03 June, 2020 |
- Global |
- 91 Pages |
- QYResearch |
- Other
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Subcutaneous Immunotherapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Subcutaneous Immunotherapy industry.
Based on our recent survey, we have several different scenarios about the Subcutaneous Immunotherapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Subcutaneous Immunotherapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Subcutaneous Immunotherapy market in terms of revenue.
Players, stakeholders, and other participants in the global Subcutaneous Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Subcutaneous Immunotherapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Subcutaneous Immunotherapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Subcutaneous Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Subcutaneous Immunotherapy market.
The following players are covered in this report:
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
...
Subcutaneous Immunotherapy Breakdown Data by Type
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Subcutaneous Immunotherapy Breakdown Data by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Asthma
- 1.4.3 Allergic Rhinitis
- 1.4.4 Venom Allergy
- 1.4.5 Food Allergy
- 1.5 Market by Application
- 1.5.1 Global Subcutaneous Immunotherapy Market Share by Application: 2020 VS 2026
- 1.5.2 Hospital Pharmacies
- 1.5.3 Online Pharmacies
- 1.5.4 Retail Pharmacies
- 1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Immunotherapy Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Subcutaneous Immunotherapy Industry
- 1.6.1.1 Subcutaneous Immunotherapy Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Subcutaneous Immunotherapy Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Subcutaneous Immunotherapy Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Subcutaneous Immunotherapy Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Subcutaneous Immunotherapy Market Perspective (2015-2026)
- 2.2 Subcutaneous Immunotherapy Growth Trends by Regions
- 2.2.1 Subcutaneous Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Subcutaneous Immunotherapy Historic Market Share by Regions (2015-2020)
- 2.2.3 Subcutaneous Immunotherapy Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Subcutaneous Immunotherapy Market Growth Strategy
- 2.3.6 Primary Interviews with Key Subcutaneous Immunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Subcutaneous Immunotherapy Players by Market Size
- 3.1.1 Global Top Subcutaneous Immunotherapy Players by Revenue (2015-2020)
- 3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Subcutaneous Immunotherapy Market Concentration Ratio
- 3.2.1 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Subcutaneous Immunotherapy Revenue in 2019
- 3.3 Subcutaneous Immunotherapy Key Players Head office and Area Served
- 3.4 Key Players Subcutaneous Immunotherapy Product Solution and Service
- 3.5 Date of Enter into Subcutaneous Immunotherapy Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Subcutaneous Immunotherapy Historic Market Size by Type (2015-2020)
- 4.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2021-2026)
5 Subcutaneous Immunotherapy Breakdown Data by Application (2015-2026)
- 5.1 Global Subcutaneous Immunotherapy Market Size by Application (2015-2020)
- 5.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Subcutaneous Immunotherapy Market Size (2015-2020)
- 6.2 Subcutaneous Immunotherapy Key Players in North America (2019-2020)
- 6.3 North America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 6.4 North America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Subcutaneous Immunotherapy Market Size (2015-2020)
- 7.2 Subcutaneous Immunotherapy Key Players in Europe (2019-2020)
- 7.3 Europe Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 7.4 Europe Subcutaneous Immunotherapy Market Size by Application (2015-2020)
8 China
- 8.1 China Subcutaneous Immunotherapy Market Size (2015-2020)
- 8.2 Subcutaneous Immunotherapy Key Players in China (2019-2020)
- 8.3 China Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 8.4 China Subcutaneous Immunotherapy Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Subcutaneous Immunotherapy Market Size (2015-2020)
- 9.2 Subcutaneous Immunotherapy Key Players in Japan (2019-2020)
- 9.3 Japan Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 9.4 Japan Subcutaneous Immunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Subcutaneous Immunotherapy Market Size (2015-2020)
- 10.2 Subcutaneous Immunotherapy Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 10.4 Southeast Asia Subcutaneous Immunotherapy Market Size by Application (2015-2020)
11 India
- 11.1 India Subcutaneous Immunotherapy Market Size (2015-2020)
- 11.2 Subcutaneous Immunotherapy Key Players in India (2019-2020)
- 11.3 India Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 11.4 India Subcutaneous Immunotherapy Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Subcutaneous Immunotherapy Market Size (2015-2020)
- 12.2 Subcutaneous Immunotherapy Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Subcutaneous Immunotherapy Market Size by Type (2015-2020)
- 12.4 Central & South America Subcutaneous Immunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Anergis
- 13.1.1 Anergis Company Details
- 13.1.2 Anergis Business Overview and Its Total Revenue
- 13.1.3 Anergis Subcutaneous Immunotherapy Introduction
- 13.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2015-2020))
- 13.1.5 Anergis Recent Development
- 13.2 HAL Allergy Group
- 13.2.1 HAL Allergy Group Company Details
- 13.2.2 HAL Allergy Group Business Overview and Its Total Revenue
- 13.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
- 13.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.2.5 HAL Allergy Group Recent Development
- 13.3 Merck
- 13.3.1 Merck Company Details
- 13.3.2 Merck Business Overview and Its Total Revenue
- 13.3.3 Merck Subcutaneous Immunotherapy Introduction
- 13.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.3.5 Merck Recent Development
- 13.4 Allergy Therapeutics
- 13.4.1 Allergy Therapeutics Company Details
- 13.4.2 Allergy Therapeutics Business Overview and Its Total Revenue
- 13.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
- 13.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.4.5 Allergy Therapeutics Recent Development
- 13.5 ALK-Abello
- 13.5.1 ALK-Abello Company Details
- 13.5.2 ALK-Abello Business Overview and Its Total Revenue
- 13.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
- 13.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.5.5 ALK-Abello Recent Development
- 13.6 Stallergenes Greer
- 13.6.1 Stallergenes Greer Company Details
- 13.6.2 Stallergenes Greer Business Overview and Its Total Revenue
- 13.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
- 13.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.6.5 Stallergenes Greer Recent Development
- 13.7 Laboratorios LETI
- 13.7.1 Laboratorios LETI Company Details
- 13.7.2 Laboratorios LETI Business Overview and Its Total Revenue
- 13.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
- 13.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2015-2020)
- 13.7.5 Laboratorios LETI Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Subcutaneous Immunotherapy. Industry analysis & Market Report on COVID-19 Impact on Global Subcutaneous Immunotherapy is a syndicated market report, published as COVID-19 Impact on Global Subcutaneous Immunotherapy Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Subcutaneous Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
